A 'suicide' CRISPR-Cas9 system to promote gene deletion and restoration by electroporation in Cryptococcus neoformans

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Wang, Yu ^a   Wei, Dongsheng ^a   Zhu, Xiangyang ^a   Pan, Jiao ^a   Zhang, Ping ^a   Huo, Liang ^b   Zhu, Xudong ^a,b  

^a NANKAI UNIVERSITY   (China)

^b BEIJING NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CRISPR CAS SYSTEM; CRYPTOCOCCUS NEOFORMANS; ELECTROPORATION; FUNGAL GENOME; GENE DELETION; GENE EDITING; GENETICS; PROCEDURES;

CRISPR-CAS SYSTEMS; CRYPTOCOCCUS NEOFORMANS; ELECTROPORATION; GENE DELETION; GENE EDITING; GENOME, FUNGAL;

EID: 84981215186     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep31145     Document Type: Article

References (34)

1. Wiedenheft, B., Sternberg, S. H. & Doudna, J. A. RNA-guided genetic silencing systems in bacteria and archaea. Nature 482, 331-338 (2012).
2. Bhaya, D., Davison, M. & Barrangou, R. CRISPR-Cas systems in bacteria and archaea: versatile small RNAs for adaptive defense and regulation. Annual review of genetics 45, 273-297 (2011).
3. Terns, M. P. & Terns, R. M. CRISPR-based adaptive immune systems. Current opinion in microbiology 14, 321-327 (2011).
4. Doudna, J. A. & Charpentier, E. The new frontier of genome engineering with CRISPR-Cas9. Science 346, 1258096 (2014).
5. Zhang, X.-H., Tee, L. Y., Wang, X.-G., Huang, Q.-S. & Yang, S.-H. Off-Target Effects in CRISPR/Cas9-mediated Genome Engineering. Molecular Therapy-Nucleic Acids 4, e264 (2015).
6. Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819-823 (2013).
7. Jinek, M. et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816-821 (2012).
8. Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339, 823-826 (2013).
9. Shalem, O., Sanjana, N. E. & Zhang, F. High-Throughput functional genomics using CRISPR-Cas9. Nature Reviews Genetics 16, 299-311 (2015).
10. Cradick, T. J., Fine, E. J., Antico, C. J. & Bao, G. CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-Target activity. Nucleic acids research, gkt714 (2013).
11. Fu, Y. et al. High-frequency off-Target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nature biotechnology 31, 822-826 (2013).
12. DiCarlo, J. E. et al. Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems. Nucleic acids research 41, 4336-4343, doi: 10.1093/nar/gkt135 (2013).
13. Jacobs, J. Z., Ciccaglione, K. M., Tournier, V. & Zaratiegui, M. Implementation of the CRISPR-Cas9 system in fission yeast. Nature communications 5 (2014).
14. Jakočiunas, T., Jensen, M. K. & Keasling, J. D. CRISPR/Cas9 advances engineering of microbial cell factories. Metabolic engineering 34, 44-59 (2016).
15. Dumesic, P. A. et al. Stalled spliceosomes are a signal for RNAi-mediated genome defense. Cell 152, 957-968 (2013).
16. Idnurm, A. et al. Deciphering the model pathogenic fungus Cryptococcus neoformans. Nature Reviews Microbiology 3, 753-764 (2005).
17. Davidson, R. C. et al. Gene disruption by biolistic transformation in serotype D strains of Cryptococcus neoformans. Fungal Genetics and Biology 29, 38-48 (2000).
18. Chang, Y. C. & Kwon-Chung, K. Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence. Molecular and Cellular Biology 14, 4912-4919 (1994).
19. Chang, Y. & Kwon-Chung, K. Isolation of the third capsule-Associated gene, CAP60, required for virulence in Cryptococcus neoformans. Infection and Immunity 66, 2230-2236 (1998).
20. Chang, Y. C., Penoyer, L. A. & Kwon-Chung, K. The second capsule gene of Cryptococcus neoformans, CAP64, is essential for virulence. Infection and Immunity 64, 1977-1983 (1996).
21. Salas, S., Bennett, J., Kwon-Chung, K., Perfect, J. & Williamson, P. Effect of the laccase gene CNLAC1, on virulence of Cryptococcus neoformans. The Journal of experimental medicine 184, 377-386 (1996).
22. Varma, A. & Kwon-Chung, K. Formation of a minichromosome in Cryptococcus neoformans as a result of electroporative transformation. Current genetics 26, 54-61 (1994).
23. Liu, H., Cottrell, T. R., Pierini, L. M., Goldman, W. E. & Doering, T. L. RNA interference in the pathogenic fungus Cryptococcus neoformans. Genetics 160, 463-470 (2002).
24. Goins, C. L., Gerik, K. J. & Lodge, J. K. Improvements to gene deletion in the fungal pathogen Cryptococcus neoformans: Absence of Ku proteins increases homologous recombination, and co-Transformation of independent DNA molecules allows rapid complementation of deletion phenotypes. Fungal Genetics and Biology 43, 531-544 (2006).
25. Varma, A. & Kwon-Chung, K. Characterization of the L41 gene in Cryptococcus neoformans: its application as a selectable transformation marker for cycloheximide resistance. Yeast 16, 1397-1403 (2000).
26. Lin, X., Chacko, N., Wang, L. & Pavuluri, Y. Generation of stable mutants and targeted gene deletion strains in Cryptococcus neoformans through electroporation. Medical mycology, myu083 (2014).
27. Li, Z. et al. Requirement of a Tsp2-Type tetraspanin for laccase repression and stress resistance in the basidiomycete Cryptococcus neoformans. Applied and environmental microbiology 78, 21-27 (2012).
28. Ost, K. S., OMeara, T. R., Huda, N., Esher, S. K. & Alspaugh, J. A. The Cryptococcus neoformans alkaline response pathway: Identification of a novel Rim pathway activator. Plos genetics 11, e1005159 (2015).
29. Mansour, S. L., Thomas, K. R. & Capecchi, M. R. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: A general strategy for targeting mutations to non-selectable genes. Nature 336, 348-352 (1988).
30. Siewers, V. An overview on selection marker genes for transformation of Saccharomyces cerevisiae. Yeast Metabolic Engineering: Methods and Protocols, 3-15 (2014).
31. Chang, Y. & Kwon-Chung, K. Isolation, characterization, and localization of a capsule-Associated gene, CAP10, of Cryptococcus neoformans. Journal of bacteriology 181, 5636-5643 (1999).
32. Mortensen, R. Overview of gene targeting by homologous recombination. Current protocols in molecular biology, 23.21. 21-23.22. 12 (2006).
33. Xie, S., Shen, B., Zhang, C., Huang, X. & Zhang, Y. sgRNAcas9: A software package for designing CRISPR sgRNA and evaluating potential off-Target cleavage sites. Plos One 9, e100448 (2014).
34. Zhang, P. et al. Cryptococcal phosphoglucose isomerase is required for virulence factor production, cell wall integrity and stress resistance. FEMS yeast research 15, fov072 (2015).